Pharming Group N.V.

NASDAQ: PHAR · Real-Time Price · USD
11.75
0.37 (3.25%)
At close: Aug 15, 2025, 3:50 PM
11.60
-1.28%
After-hours: Aug 15, 2025, 05:26 PM EDT

Pharming Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Aug 5, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
1.06M -4.79M -5.43M -14.83M -13.03M -8.45M -12.7M -28.06M -22.09M -5.92M 14.99M 34.71M 26.34M 14.13M 22.31M 8.08M 30.88M 38.42M
Depreciation & Amortization
13.03M 12.74M 16.06M 15.98M 16.13M 19.59M 15.99M 15.34M 14.39M 13.3M 13.19M 17.02M 17.26M 17.64M 17.45M 9.62M 9.89M 9.07M
Stock-Based Compensation
8.14M 11.4M 11.25M 11.92M 10.97M 10.12M 9.25M 7.8M 7.48M 6.88M 6.39M 7.39M 7.53M 7.62M 8.4M 5.52M 3.74M 1.85M
Other Working Capital
-9.97M -2.84M 73.56K 6.59M 6.54M -325.97K -208.22K 454.63K 761.42K 438.87K -2.83M 75.27K 3.59M -1.12M 688.27K -1.87M -11.73M 1.44M
Other Non-Cash Items
6.15M 6.56M 11.91M 36.65M 40.16M 34.14M 25.59M 12.16M 10.77M -7.59M -11.28M -24.57M -24.74M -1.63M -7.59M 32.53M 34.13M 29.66M
Deferred Income Tax
n/a n/a n/a -19.35M -18.17M -38.44M -38.44M -19.08M -20.27M n/a n/a -204K -323.05K -634.73K -706.24K -502.24K -383.19K -71.51K
Change in Working Capital
3.34M -7.56M -10.06M -3.78M -15.69M -5.25M -16.38M -11.36M -4.4M -7.17M -387K -3.51M -2.83M -8.54M -5.03M -6.83M -16.26M -2.48M
Operating Cash Flow
31.72M 6.13M -3.78M -931.34K -7.15M -3.59M -16.7M -23.2M -14.12M -497K 22.9M 30.84M 23.24M 28.59M 34.83M 48.42M 62.01M 76.45M
Capital Expenditures
-913.99K -996.65K -788.46K -990.98K -771.98K -1.33M -1.46M -1.45M -1.41M -1.82M -1.98M -6.92M -9.44M -13.01M -15.51M -14.8M -13.74M -12.41M
Cash Acquisitions
-58.35M -57.89M n/a n/a 145.68M 145.68M 145.68M 145.6M -278K 7.3M 7.3M 7.38M 7.58M -385.68K -0.97 -354.23K -339.61K 23.74K
Purchase of Investments
-171.88M -189.58M -284.14M -372.4M -494.88M -477.16M -382.61M -232.17M 287.7K -7.26M -7.26M -7.4M -7.59M -39K -39K n/a n/a n/a
Sales Maturities Of Investments
252.63M 289.17M 316.6M 410.77M 382.74M 328.47M 233.17M 86.57M -244.82K 7.3M 7.3M 7.32M 7.55M n/a n/a n/a n/a n/a
Other Investing Acitivies
-109.67K -2.29M -1.61M -1.43M -146.75M -123.48M -124.17M -124.43M 21.04M -43.88K -42.88K 44.9K -4.44M -4.44M -4.44M -4.44M -0.00 -0.00
Investing Cash Flow
21.37M 40.59M 31.56M 37.44M -112.48M -128.51M -129.39M -125.88M 19.4M 5.48M 5.32M 427K -6.35M -17.88M -19.99M -19.59M -14.08M -12.38M
Debt Repayment
-3.42M -34.31M -34.82M -34.46M -34.28M -4.65M -4.63M -4.4M -4.18M -3.71M -3.31M -3.2M -3.21M -3.49M -3.14M 3.58M 8M 9.4M
Common Stock Repurchased
n/a n/a n/a n/a n/a -636.9K -636.9K -636.9K -636.9K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-9.49M -5.53M -774.5K 1.24M 7.73M 4.63M 3.76M 3.66M -4.53M -3.97M -3.95M -5.22M -4.64M -25.91M -26.41M -28.16M -30.61M -10.08M
Financial Cash Flow
-10.67M -38.62M -32.34M -31.17M -24.49M 1.14M -1.05M 259K -6.9M -4.72M -4.98M -5.68M -5.92M -27.84M -27.26M -23.3M -21.1M 2.52M
Net Cash Flow
47.67M 8.2M -6.8M 5.8M -145.44M -133.1M -145.81M -134.05M 2.41M -4.89M 15.42M 8.08M 4.26M -13.9M -1.25M 9.73M 23.63M 65.73M
Free Cash Flow
30.8M 5.13M -4.58M -1.92M -7.92M -4.92M -18.16M -24.65M -15.52M -2.31M 20.92M 23.93M 13.79M 15.58M 19.32M 33.62M 48.27M 64.04M